Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| anti-CGRP monoclonal antibodies NCT07103694 · i-NEED: NEw migrainE Drugs Database | Migraine | Traitement symptomatique | À vérifier | RECRUITING | Approved by the Food and Drug Administration (FDA) and the European Medici… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:08 | Détail |
| Eptinezumab 100 or 300 mg ev NCT06409845 · TACHIS — Effectiveness and Tolerability of Eptinezumab | Migraine | À vérifier | À vérifier | COMPLETED | The purpose of this prospective and multicentric study is to evaluate the… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:08 | Détail |
| filiform needling NCT07633522 · Fire Needling Plus Filiform Needling for Chronic Migraine With Comorbid Tension-… | Migraine | Traitement symptomatique · Thérapie génique | Non applicable | NOT_YET_RECRUITING | The investigators conducted a multicenter, prospective, randomized control… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:08 | Détail |
| Ketamine NCT05306899 · KetHead — Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily H… | Migraine | Traitement symptomatique | Phase 3 | RECRUITING | Chronic daily headaches (CDH) poses a significant burden on patients, heal… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:08 | Détail |
| Lidocaine (drug) NCT07061847 · Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Mi… | Migraine | Traitement symptomatique | Phase 2 | RECRUITING | The main purpose of this study is to evaluate the effectiveness of a new t… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:08 | Détail |
| RHUMIL-6 — Efficacy of Anti-IL-6 Treatments on Migraine in Patients T… NCT07598045 · NCT07598045 | Migraine | Immunomodulation | À vérifier | NOT_YET_RECRUITING | Migraine affects approximately 15% of the global population. Its prevalenc… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:08 | Détail |
| RLB — Determining the Utility of a Behavioral Intervention in Chronic… NCT05415020 · NCT05415020 | Migraine | À vérifier | Non applicable | RECRUITING | This proposal will involve a pilot study to evaluate the feasibility, acce… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:08 | Détail |
| SCP — Supraspinal Processing of Sensory Aspects of Pain NCT05814497 · NCT05814497 | Migraine | Traitement symptomatique · Thérapie génique | Non applicable | RECRUITING | The goal of this basic science study is to learn about the brain mechanism… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:08 | Détail |
| Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and… NCT07644299 · NCT07644299 | Migraine | Ralentissement de la progression · Traitement symptomatique · Thérapie génique | Non applicable | NOT_YET_RECRUITING | Migraine is one of the most common and disabling neurological conditions w… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:08 | Détail |
| SIGMA — The Neuroanatomical and Psychological Correlates of Suggestib… NCT07617441 · NCT07617441 | Migraine | Ralentissement de la progression · Traitement symptomatique · Thérapie génique | À vérifier | RECRUITING | Chronic migraine is a disabling neurovascular disorder and one of the lead… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:08 | Détail |
| Atogepant NCT06810505 · A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease… | Migraine | Traitement symptomatique | Phase 3 | RECRUITING | A migraine attack is a moderate or severe headache that usually occurs on… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:07 | Détail |
| Atogepant NCT05748483 · ATO-TOPIRAMATE — Comparative Study of Oral Atogepant Versus Oral Topiramate to A… | Migraine | Traitement symptomatique | Phase 3 | COMPLETED | A migraine attack is a moderate or severe headache that usually occurs on… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:07 | Détail |
| Atogepant NCT05216263 · ATO-BOTOX — Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to… | Migraine | Traitement symptomatique | Phase 3 | COMPLETED | A migraine attack is a moderate or severe headache that usually occurs on… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:07 | Détail |
| Blood sampling, questionnaire and phone call NCT07067112 · SIIM-reg — Suppressive Functions of Regulatory T Cells in Migraine | Migraine | Immunomodulation · Traitement symptomatique | Non applicable | NOT_YET_RECRUITING | Migraine is a frequent, disabling condition, of great social and economica… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:07 | Détail |
| CEREB — Evolution of the Cognitive Profile and Quality of Life of Adu… NCT07691164 · NCT07691164 | Migraine | À vérifier | Non applicable | NOT_YET_RECRUITING | In chronic migraine, we routinely use innovative treatments such as peri-c… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:07 | Détail |
| Eptinezumab NCT05164172 · REJOIN — A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) Wi… | Migraine | Traitement symptomatique | Phase 3 | RECRUITING | Most individuals with mild traumatic brain injury (mTBI) experience post-t… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:07 | Détail |
| Lu AG09222 NCT06323928 · PROCEED — A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have… | Migraine | À vérifier | Phase 2 | COMPLETED | The purpose of this trial is to determine which doses of Lu AG09222 are re… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:07 | Détail |
| Middle Meningeal Artery embolization NCT06735833 · MMA Embolization for Refractory Chronic Migraine | Migraine | À vérifier | Non applicable | RECRUITING | This is a prospective, multi-center, feasibility study to investigate safe… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:07 | Détail |
| Middle Meningeal Artery embolization NCT07652034 · EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Fol… | Migraine | À vérifier | À vérifier | NOT_YET_RECRUITING | This is a prospective, multi-center, feasibility study to investigate safe… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:07 | Détail |
| Mind Body Balance for Pediatric Migraine NCT04715685 · NCT04715685 | Migraine | À vérifier | Non applicable | RECRUITING | This study uses a factorial research design to evaluate a nurse delivered… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:07 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| An evaluation of peripheral nerve damage that may develop following i… Bupivacaine HCl 0.5% Injectable Solution · PMID 42251255 | Migraine | Immunomodulation | Publication | PubMed | Voir la publication source This study aimed to investigate the histopathological, electrophysiological, functional, biochemical, and inflammatory… | BMC anesthesiology 2026-08-16 19:24:47 | Source |
| Does Liposomal Bupivacaine Provide Superior Postoperative Analgesia C… Bupivacaine HCl 0.5% Injectable Solution · PMID 42284069 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Choosing the most effective pain management is important for enhancing functional recovery after surgery. The fascia il… | Clinical orthopaedics and related research 2026-08-16 19:24:47 | Source |
| Long-term durability of a time-limited methotrexate intervention in p… Methylprednisolone 40 MG Injection · PMID 42392130 | Migraine | Ralentissement de la progression · Immunomodulation | Publication | PubMed | Voir la publication source The TREAT EARLIER trial showed that a time-limited intervention with 12 months of methotrexate in individuals with arth… | The Lancet. Rheumatology 2026-08-16 19:24:47 | Source |
| The true benefit of the regional block in orthognathic surgery lies i… Bupivacaine HCl 0.5% Injectable Solution · PMID 41790271 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source PURPOSE: The objective of this study was to ascertain the actual benefits of regional analgesia in orthognathic surgery… | Oral and maxillofacial surgery 2026-08-16 19:24:47 | Source |
| Use and safety of corticosteroid injections in joints and musculoskel… Methylprednisolone 40 MG Injection · PMID 40015722 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Intra-articular corticosteroid (IACS) injection and peri-articular corticosteroid injection are commonly used to treat… | Regional anesthesia and pain medicine 2026-08-16 19:24:47 | Source |
| Biofeedback in the prophylactic treatment of medication overuse heada… Neurofeedback for Episodic Migraine · PMID 27655371 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Medication overuse headache (MOH) is a major clinical concern and a common health risk. Recent literature stressed the… | The journal of headache and pain 2026-08-16 19:24:46 | Source |
| Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome… Neurofeedback for Episodic Migraine · PMID 20205867 | Migraine | Ralentissement de la progression · Traitement symptomatique | Publication | PubMed | Voir la publication source Traditional peripheral biofeedback has grade A evidence for effectively treating migraines. Two newer forms of neurobio… | Behavioral and brain functions : BBF 2026-08-16 19:24:46 | Source |
| L5-S1 basivertebral nerve ablation for chronic vertebrogenic low back… Chiropractic Care · PMID 42582823 | Migraine | Ralentissement de la progression · Immunomodulation · Traitement symptomatique | Publication | PubMed | Voir la publication source Basivertebral nerve ablation (BVNA) is an established treatment for vertebrogenic low back pain associated with Modic e… | Journal of spine surgery (Hong Kong) 2026-08-16 19:24:45 | Source |
| Latent Patterns of Complementary and Integrative Health Therapy Utili… Chiropractic Care · PMID 42503189 | Migraine | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Complementary and integrative health (CIH) therapies offer safe and effective alternatives for pain management, and use… | Pain medicine (Malden, Mass.) 2026-08-16 19:24:45 | Source |
| Resolution of Treatment-Resistant Vertigo and Suspected Ménière's Dis… Chiropractic Care · PMID 42534238 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Ménière's disease and related peripheral vestibular disorders are notoriously difficult to manage, and many patients re… | Cureus 2026-08-16 19:24:45 | Source |
| E-selectin and TFPI are associated with carotid intima-media thicknes… Atorvastatin 20mg · PMID 17889518 | Migraine | Immunomodulation | Publication | PubMed | Voir la publication source MIAMI was a prospective multicenter clinical study designed to investigate the relationship between changes in carotid… | Nutrition, metabolism, and cardiovascular diseases : N… 2026-08-16 19:24:43 | Source |
| Evaluation of Flavonoid-rich Fraction of Aerial Part Extract in Ather… Atorvastatin 20mg · PMID 37807415 | Migraine | Neuroprotection · Ralentissement de la progression · Immunomodulation | Publication | PubMed | Voir la publication source is a tiny, upright herb that contains a variety of chemical components, including alkaloids, glycosides, mucilage, prot… | Combinatorial chemistry & high throughput screening 2026-08-16 19:24:43 | Source |
| Expert consensus on drug treatment of chronic subdural hematoma. Atorvastatin 20mg · PMID 34809712 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Chronic subdural hematoma (CSDH) is a chronic space-occupying lesion formed by blood accumulation between arachnoid and… | Chinese neurosurgical journal 2026-08-16 19:24:43 | Source |
| Effects of erenumab on migraine aura frequency: a REFORM study. Erenumab Dose 1 · PMID 41888647 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies effectively prevent migraine headache, but their impa… | The journal of headache and pain 2026-08-16 19:24:39 | Source |
| Efficacy and Safety of Erenumab in Adults With Medication Overuse Hea… Erenumab Dose 1 · PMID 40838472 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Erenumab-induced medication overuse headache (MOH) remission in participants with chronic migraine (CM) in a prospectiv… | European journal of neurology 2026-08-16 19:24:39 | Source |
| Erenumab for Chronic Cluster Headache: A Randomized Clinical Trial. Erenumab Dose 1 · PMID 40526384 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Calcitonin gene-related peptide (CGRP) is involved in the pathophysiology of cluster headache (CH). Prophylactic pharma… | JAMA network open 2026-08-16 19:24:39 | Source |
| Neuro-Immune Axis in Trauma-Induced Heterotopic Ossification: Mechani… Erenumab Dose 2 · PMID 42121928 | Migraine | Immunomodulation · Thérapie génique | Publication | PubMed | Voir la publication source Trauma-induced heterotopic ossification (tHO) is characterized by aberrant ectopic bone formation in soft tissue follow… | Cells 2026-08-16 19:24:39 | Source |
| Advances in ERAS to Reduce the Incidence of Chronic Post-Surgical Pai… Lidocaine Procedure · PMID 42138101 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Chronic postsurgical pain (CPSP) remains a clinically significant complication following major surgery, contributing to… | Journal of investigative surgery : the official journa… 2026-08-16 19:24:38 | Source |
| Comparison of a TrachoSpray Device and Manual Lidocaine Spray on Hemo… Lidocaine Procedure · PMID 41797600 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Postoperative sore throat (POST) is an distressing complication following endotracheal intubation, particularly with do… | Journal of investigative surgery : the official journa… 2026-08-16 19:24:38 | Source |
| Lidocaine Spray Versus Viscous Lidocaine Solution Plus Lidocaine Spra… Lidocaine Procedure · PMID 42559051 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Non-sedated esophagogastroduodenoscopy (EGD) is preferred in patients at risk from sedatives. However, achieving effect… | DEN open 2026-08-16 19:24:38 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |